2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow DE-120: new trials by email Literature Review of DE-120 trials Research Report on DE-120
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration DE-120, Aflibercept - Age-Related Macular Degeneration | Phase 2 | Completed | Santen Inc. | 16 | 2015-04-01 | 2018-04-18 |
| A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration DE-120 - Age-Related Macular Degeneration | Phase 1 / Phase 2 | Completed | Santen Inc. | 10 | 2014-01-01 | 2018-04-18 |
Santen Inc. (2)
United States (2)